A Cost-Effectiveness Analysis of Adherence Promotion Strategies to Improve Rejection Rates in Adolescent Kidney Transplant Patients
Friday, April 22, 2022
6:30 PM – 6:45 PM US MT
Location: Convention Center: 708/710/712
CE: Enduring CME: 0.25
Publication Number: 595.2
Charles Varnell, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Kristin L. Rich, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Avani C. Modi, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States; Mark H. Eckman, University of Cincinnati College of Medicine, Cincinnati, OH, United States; David K. Hooper, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States
Presenting Author(s)
CV
Charles Varnell, Jr., MD
Assistant Professor of Pediatrics Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
Participants should be aware of the following financial/non-financial relationships:
Charles Varnell, Jr., MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Kristin L. Rich, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Avani C. Modi, Ph.D.: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Mark H. Eckman, MD, MS: ● Bristol-Myers Squibb (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
David K. Hooper, MD, MS: ● Alnylam (Currently Ongoing) (Products/Services: Advisory Committee). ● BioPorto Diagnostics A/S (Currently Ongoing) (Products/Services: Consultant). ● Hive Networks Inc (Currently Ongoing) (Products/Services: Consultant). ● Kaneka Pharma America LLC (Currently Ongoing) (Products/Services: Consultant). ● Magnolia Innovation (Ended In the Past 24 Months) (Products/Services: Consultant). ● Natera Inc. (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
